Avvaa World Health Care Products, Inc.OTC: AVVH

AVVAA Files Form with BCSC to Cease Being a Reporting Company in British Columbia

· Issued by Avvaa World Health Care Products, Inc.

avVaa World Health Care Products

7400 Beaufont Springs Drive, Suite 300 Richmond, VA 23225 United States

N E W S   R E L E A S E

AVVAA Files Form with BCSC to Cease Being a Reporting Company in British Columbia

Richmond, Virginia, October 10, 2013 ? avVaa World Health Care Products ("the Company") (Pink Sheets: AVVH) announces it has filed the required form to SEDAR to notify the British Columbia Securities Commission that the company wishes to cease to be a reporting entity to the BCSC. "This was the final step necessary for the transition of moving the company and its corporate headquarters to the United States," said Jason Price, CEO of avVaa.  "Once the petition is granted, we will no longer have the obligation of reporting financials or other corporate governance information to the BCSC."

About avVaa World Health Care Products

avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers.  avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne.  avVaa is poised to manufacture and market its OTC Neuroskin? line of skin care products through mass food and drug channels in the United States and globally.  The Company's secondary line of equine and pet care related products are already being distributed throughout all of Canada.  For more information, visit: www.avvaa.com.

Jason Price Chairman & CEO

avVaa World Health Care Products

P:  1-866-864-6598

E:  jason.price@avvaa.com   www.avvaa.com   

Pink Sheets:  AVVH

Safe Harbor

This news release contains statements which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995.  Those statements include statements regarding the intent, belief or current expectations of avVaa World Health Care Products, and members of its management, as well as the assumptions on which such statements are based.  Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements.  Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions.  The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.  Potential risks and uncertainties include, but are not limited to, the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.

Earlier from Avvaa World Health Care Products

All Avvaa World Health Care Products news releases